Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
What is Jiangsu Deyuan Pharmaceutical Co OCF Margin %?
Jiangsu Deyuan Pharmaceutical CoBJSE:920735 97 OCF Margin % is 10.66% as of Jun. 2026, which is 22% below its 10-year median of 13.63. GuruFocus rates BJSE:920735 with a GF Score™ of 97/100 and a GF Value™ of ¥29.61 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 962 Drug Manufacturers companies, Jiangsu Deyuan Pharmaceutical Co ranks better than 71.93% on this metric.
The historical rank and industry rank for Jiangsu Deyuan Pharmaceutical Co's OCF Margin % or its related term are showing as below:
BJSE:920735'
s OCF Margin % Range Over the Past 10 Years
Min: 8.73 Med: 13.63 Max: 21.05
Current: 17.22
During the past 13 years, the highest OCF Margin % of Jiangsu Deyuan Pharmaceutical Co was 21.05%. The lowest was 8.73%. And the median was 13.63%.
BJSE:920735's OCF Margin % is ranked better than 71.93% of 962
companies
in the Drug Manufacturers industry
Industry Median: 10.08
vs BJSE:920735: 17.22
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Deyuan Pharmaceutical Co OCF Margin % Chart
For the Drug Manufacturers - Specialty & Generic subindustry, Jiangsu Deyuan Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jiangsu Deyuan Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Jiangsu Deyuan Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Jiangsu Deyuan Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) has a OCF Margin % of 10.66% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors. This is 22% below median its historical median of 13.63. Over the past decade, Jiangsu Deyuan Pharmaceutical Co's OCF Margin % has ranged from 8.73 to 21.05. According to the industry distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #270 out of 962 companies in the Drug Manufacturers industry, placing it in the top 28.1%.
Is Jiangsu Deyuan Pharmaceutical Co's OCF Margin % too high?
Jiangsu Deyuan Pharmaceutical Co's current OCF Margin % of 10.66% is 22% below median its 10-year median of 13.63. Over the past 10 years, this metric has ranged from a low of 8.73 to a high of 21.05. The Drug Manufacturers industry median OCF Margin % is 10.08. Jiangsu Deyuan Pharmaceutical Co's value of 10.66% is 5.8% above this industry median. Based on the distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #270 out of 962 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Jiangsu Deyuan Pharmaceutical Co has a GF Score™ of 97/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Jiangsu Deyuan Pharmaceutical Co's OCF Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Jiangsu Deyuan Pharmaceutical Co ranks #270 out of 962 companies for OCF Margin %. This puts Jiangsu Deyuan Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 10.08. Jiangsu Deyuan Pharmaceutical Co's value of 10.66% is 5.8% above this benchmark. Historically, Jiangsu Deyuan Pharmaceutical Co's own OCF Margin % has ranged from 8.73 to 21.05 over the past decade. While the company's 10-year median is 13.63 vs. the industry median of 10.08, Jiangsu Deyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.08, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Jiangsu Deyuan Pharmaceutical Co's current OCF Margin % of 10.66% is 5.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Jiangsu Deyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jiangsu Deyuan Pharmaceutical Co's current OCF Margin % is 10.66%, which is 22% below median its own 10-year median of 13.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jiangsu Deyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥29.61, compared to a current price of ¥26.66 — trading 10% below its estimated fair value. The current OCF Margin % is 10.66%, which is 22% below median its 10-year median of 13.63 and 5.8% above the Drug Manufacturers industry median of 10.08. Jiangsu Deyuan Pharmaceutical Co's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Jiangsu Deyuan Pharmaceutical Co (BJSE:920735), the current OCF Margin % is 10.66% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jiangsu Deyuan Pharmaceutical Co (BJSE:920735) Overvalued in 2026?
Based on GuruFocus' analysis, Jiangsu Deyuan Pharmaceutical Co stock appears to be undervalued.
The current stock price of ¥26.66 is trading 10% below its estimated GF Value™ of ¥29.61.
GuruFocus considers Jiangsu Deyuan Pharmaceutical Co to be Modestly Undervalued.
Key valuation signals for BJSE:920735:
OCF Margin %: 10.66% (22% below median its 10-year median of 13.63)
GF Value™: ¥29.61 vs. price of ¥26.66 (10% below fair value)
Industry Position: 5.8% above the Drug Manufacturers median (#270 of 962)
No single metric tells the full story. See the BJSE:920735 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BJSE:920735 has been successfully added to your 
